US Patent & Trademark Office

Viatris challenges Novo Nordiskās patent on diabetes drug semaglutide
Anika Sharma
In Viatris’ ambitious bid to be the first to introduce generic versions of Novo Nordisk’s blockbuster diabetes and obesity drugs, ...